Catalyst Biosciences, Inc. - stock earnings
Stock symbol CBIO is outdated, potentially delisted? Maybe it is available on other exchange?
CBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -2.5 million USD | ? USD |
| 2023Q1 | 260000 USD | ? USD |
| 2022Q3 | -4.9 million USD | ? USD |
| 2022Q2 | 51.6 million USD | ? USD |
| 2022Q1 | -14.5 million USD | 794000 USD |
| 2021Q4 | -20.3 million USD | 2.4 million USD |
| 2021Q3 | -25.2 million USD | 2.3 million USD |
| 2021Q2 | -19.9 million USD | 1.1 million USD |
| 2021Q1 | -22.4 million USD | 1.5 million USD |
| 2020Q4 | -18.9 million USD | 2.0 million USD |
| 2020Q3 | -16.0 million USD | 893000 USD |
CBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -87.9 million USD | 7.3 million USD |
| 2020 | -56.2 million USD | 20.9 million USD |
| 2019 | -55.2 million USD | ? USD |
| 2018 | -30.1 million USD | 6000 USD |
| 2017 | -21.6 million USD | 1.0 million USD |
CBIO
Price: $0.51
52 week price:
Dividend Yield: 792.92%
Earnings Per Share: -0.03 USD
P/E Ratio: 1.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Ebitda: -5.8 millionMarket Capitalization: 19.4 million